News & Events

• September 14, 2021
  

  VIEW NOW | 2021 RDCA-DAP® Workshop

    The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerating therapy development across rare diseases. The platform serves as a centralized and standardized infrastructure to host and share rare diseases data, to support and accelerate rare disease innovation. View the RDCA-DAP 2021 Virtual Workshop and learn......
• July 21, 2021
  

  View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease

  When: July 21, 2021, 12 p.m. ET

  Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular dystrophy

  Presenters: Varun Aggarwal, PhD, Director, Statistical and Mathematical Medicine, Quantitative Medicine; Kevin Krudys, PhD, Office of Clinical Pharmacology, FDA

  RDCA-DAP team: Jeff Barrett, PhD, FCP, Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP

• June 16, 2021
  

  View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development

  When: June 16, 2021, 12 p.m. ET

  Case Study: Modeling disease progression in polycystic kidney disease to inform trial design

  Presenters: Rhoda Muse, PhD, Scientist 1, Quantitative Medicine; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine

  RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP

• May 19, 2021
  

  View Now | Interpretation of novel biomarkers in related diseases through data interoperability in a pan-rare disease database

  When: May 19, 2021, 12 p.m. ET

  Example Disease: Polycystic kidney disease and kidney transplant

  Presenters: Jagdeep Podichetty, PhD, Director, Predictive Analytics; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine

  RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP

• April 21, 2021
  

  View Now | RDCA-DAP: Searching, visualizing and exploring data in the RDCA-DAP platform to identify data of interest for advanced analysis

  When: April 21, 2021, 12 p.m. ET
  Example Disease: Friedreich’s ataxia
  Presenters: Amanda Borens, MSc, Executive Director, Data Science, DCC; Vicki Theurer Crider, Sr. Project Manager, DCC; Kurt Michels, Data Analyst, Data Science